Cargando…

Limitations of Personalized Medicine and Gene Assays for Breast Cancer

Adjuvant systemic treatments reduce the risk of breast cancer recurrence following the local treatment of primary stage I-III breast cancers. For patients with hormone-positive breast cancers receiving hormonal therapy, the risk of distant recurrence is under 20% and therefore, many patients may pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiberi, David, Masucci, Laura, Shedid, Daniel, Roy, Isabelle, Vu, Toni, Patocskai, Erica, Robidoux, André, Wong, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393908/ https://www.ncbi.nlm.nih.gov/pubmed/28428927 http://dx.doi.org/10.7759/cureus.1100

Ejemplares similares

Helical Tomotherapy for Postmastectomy Radiotherapy after Immediate Left Breast Reconstruction: A Case Study
por: Mathieu, Dominique, et al.
Publicado: (2017)

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec
por: Hassan, Saima, et al.
Publicado: (2022)

Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer
por: Mathieu, Dominique, et al.
Publicado: (2020)

Editorial: An era of personalized medicine in breast cancer: integrating artificial intelligence into practice
por: Masood, Nosheen, et al.
Publicado: (2023)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report
por: Chennouf, Anas, et al.
Publicado: (2017)

Circulating Tumor Cells: The Substrate of Personalized Medicine?
por: Greene, Bryan T., et al.
Publicado: (2012)

Anterolateral Cervical Kyphoplasty for Metastatic Cervical Spine Lesions
por: Sebaaly, Amer, et al.
Publicado: (2018)

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015)

Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
por: Sotoudeh, Houman, et al.
Publicado: (2019)

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
por: Helgadottir, Hildur, et al.
Publicado: (2018)

Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine
por: Zhang, Yumeng, et al.
Publicado: (2020)

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
por: Fidelito, Gio, et al.
Publicado: (2022)

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer
por: Aristei, Cynthia, et al.
Publicado: (2021)

Locally advanced breast cancer arising in the axilla
por: Sapon-Cousineau, Sasha, et al.
Publicado: (2022)

Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)

Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling–informed personalized monitoring assay
por: Powles, Thomas, et al.
Publicado: (2023)

Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine
por: Eskandarion, Mohammad Reza, et al.
Publicado: (2022)

Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
por: Graham, Donna M., et al.
Publicado: (2014)

Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives
por: Li, Ling-Rui, et al.
Publicado: (2021)

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021)

The Use of Zebrafish Xenotransplant Assays to Analyze the Role of lncRNAs in Breast Cancer
por: Zampedri, Cecilia, et al.
Publicado: (2021)

Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
por: Licata, Luca, et al.
Publicado: (2023)

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
por: Azria, David, et al.
Publicado: (2018)

Ultrasound radiomics in personalized breast management: Current status and future prospects
por: Gu, Jionghui, et al.
Publicado: (2022)

Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
por: Masucci, Maria Teresa, et al.
Publicado: (2019)

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion
por: Hellinger, Johanna W., et al.
Publicado: (2019)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine
por: Hirsh, Vera
Publicado: (2015)

Development of a Drosophila Cell-Based Error Correction Assay
por: Salemi, Jeffrey D., et al.
Publicado: (2013)

Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
por: Vu, Thuy, et al.
Publicado: (2012)

Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy
por: Li, Lu, et al.
Publicado: (2021)

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
por: Meehan, James, et al.
Publicado: (2020)

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group
por: Shukla, Neerav, et al.
Publicado: (2013)

Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
por: Morgan, Katherine M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_45injfsool79miknvh8ue4g68h